The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes

被引：0
|
作者：
Nakano, Kenji [1 ]
Funauchi, Yuki [2 ]
Hayakawa, Keiko [2 ]
Tanizawa, Taisuke [2 ]
Ae, Keisuke [2 ]
Matsumoto, Seiichi [2 ]
Takahashi, Shunji [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Orthoped Surg, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz343.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1 - 126
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line
    Nakano, Kenji
    Hayakawa, Keiko
    Funauchi, Yuki
    Tanizawa, Taisuke
    Ae, Keisuke
    Matsumoto, Seiichi
    Tomomatsu, Junichi
    Ono, Makiko
    Taira, Shinichiro
    Nishizawa, Masatoshi
    Wang, Xiaofei
    Ohmoto, Akihiro
    Sato, Yasuyoshi
    Fukuda, Naoki
    Urasaki, Tetsuya
    Takahashi, Shunji
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (01) : 1 - 6
  • [2] Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcoma
    Emambux, Sheik
    Italiano, Antoine
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (08) : 819 - 824
  • [3] Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
    Schoffski, Patrick
    Ray-Coquard, Isabelle Laure
    Cioffi, Angela
    Nguyen Bin Bui
    Bauer, Sebastian
    Hartmann, Joerg Thomas
    Krarup-Hansen, Anders
    Gruenwald, Viktor
    Sciot, Raf
    Dumez, Herlinde
    Blay, Jean-Yves
    Le Cesne, Axel
    Wanders, Jantien
    Hayward, Carolyn
    Marreaud, Sandrine
    Ouali, Monia
    Hohenberger, Peter
    LANCET ONCOLOGY, 2011, 12 (11): : 1045 - 1052
  • [4] Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
    Inagaki, C.
    Shimoi, T.
    Okuma, H. S.
    Kawachi, A.
    Shimomura, A.
    Noguchi, E.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Eribulin in soft-tissue sarcoma
    Young, Robin J.
    Woll, Penella J.
    LANCET, 2016, 387 (10028): : 1594 - 1596
  • [6] Eribulin therapy for the treatment of patients with advanced soft tissue sarcoma
    Seetharam, Mahesh
    Kolla, Kantha R.
    Chawla, Sant P.
    FUTURE ONCOLOGY, 2018, 14 (16) : 1531 - 1545
  • [7] Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes (vol 12, pg 1051, 2011)
    Schoffski, P.
    Ray-Coquard, I. L.
    Cioffi, A.
    LANCET ONCOLOGY, 2015, 16 (09): : E427 - E427
  • [8] Efficacy of Eribulin in Soft Tissue Sarcomas
    Phillips, Edward
    Jones, Robin L.
    Huang, Paul
    Digklia, Antonia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China
    Yang, Zhixun
    Zheng, Rongshou
    Zhang, Siwei
    Zeng, Hongmei
    Li, He
    Chen, Wanqing
    CANCER BIOLOGY & MEDICINE, 2019, 16 (03) : 565 - 574
  • [10] Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China
    Zhixun Yang
    Rongshou Zheng
    Siwei Zhang
    Hongmei Zeng
    He Li
    Wanqing Chen
    Cancer Biology & Medicine, 2019, 16 (03) : 565 - 574
12345